Eli Lilly: The One-Way Ride Can't Last Forever (Rating Downgrade)

2026-03-06 09:30:00 ET

Eli Lilly: Are The Best Days Over?

It seems like the market is ready to look past the previous winners in the healthcare sector, and that includes Eli Lilly ( LLY ), unfortunately. It shouldn't have escaped the lens of investors that LLY gained just under 7% in the past one year. While it is undoubtedly way ahead of its archrival Novo Nordisk’s ( NVO ) catastrophic 56% decline in the past 1 year, LLY appears to be trailing some of its healthcare peers right now....

Read the full article on Seeking Alpha

For further details see: